Cardiac damage induced by immunization with heat-killed Trypanosoma cruzi is not antibody mediated

Parasite Immunology

Volumn 35, Issue 1, 2013, Pages 1-10

  Bonney, K M ^a   Gifford, K M ^a   Taylor, J M ^a   Chen, C I ^a   Engman, D M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Antibody; Chagas disease; Heat killed; Immunization; Mouse

Indexed keywords

AUTOANTIBODY; HEART ANTIBODY; TROPONIN I;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; CARDITIS; CONTROLLED STUDY; HEART INJURY; HEART MUSCLE; IMMUNIZATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRYPANOSOMA CRUZI;

ANIMALS; ANTIBODIES; AUTOIMMUNITY; CHAGAS DISEASE; MALE; MICE; MYOCARDIUM; TRYPANOSOMA CRUZI;

MUS; TRYPANOSOMA CRUZI;

EID: 84871110681     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/pim.12008     Document Type: Article

References (39)

1. Tanowitz HB, Machado FS, Jelicks LA, et al. Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease). Prog Cardiovasc Dis 2009; 51: 524-539.
2. Santos-Buch CA & Teixeira AR. The immunology of experimental Chagas' disease. 3. Rejection of allogeneic heart cells in vitro. J Exp Med 1974; 140: 38-53.
3. Leon JS, Godsel LM, Wang K & Engman DM. Cardiac myosin autoimmunity in acute Chagas heart disease. Infect Immun 2001; 69: 5643-5649.
4. Girones N, Carrasco-Marin E, Cuervo H, et al. Role of Trypanosoma cruzi autoreactive T cells in the generation of cardiac pathology. Ann NY Acad Sci, 2007; 1107: 434-444.
5. + T cells against myosin in mice chronically infected with Trypanosoma cruzi. Infect Immun 1989; 57: 2640-2644.
6. Bonfa E, Viana VST, Barreto ACP, Yoshinari NH & Cossermelli W. Autoantibodies in Chagas' disease. An antibody cross-reactive with human and Trypanosoma cruzi ribosomal proteins. J Immunol 1993; 150: 3917-3923.
7. Tarleton RL. Depletion of CD8+ T cells increases susceptibility and reverses vaccine-induced immunity in mice infected with Trypanosoma cruzi. J Immunol 1990; 144: 717-724.
8. Sun J & Tarleton RL. Predominance of CD8+ T lymphocytes in the inflammatory lesions of mice with acute Trypanosoma cruzi infection. Am J Trop Med Hyg 1993; 48: 161-169.
9. Sato MN, Yamashiro-Kanashiro EH, Tanji MM, Kaneno R, Higuchi ML & Duarte AJ. CD8 + cells and natural cytotoxic activity among spleen, blood, and heart lymphocytes during the acute phase of Trypanosoma cruzi infection in rats. Infect Immun 1992; 60: 1024-1030.
10. Hoft DF, Schnapp AR, Eickhoff CS & Roodman ST. Involvement of CD4(+) Th1 cells in systemic immunity protective against primary and secondary challenges with Trypanosoma cruzi. Infect Immun 2000; 68: 197-204.
11. Tarleton RL, Sun J, Zhang L & Postan M. Depletion of T-cell subpopulations results in exacerbation of myocarditis and parasitism in experimental Chagas' disease. Infect Immun 1994; 62: 1820-1829.
12. Laucella SA, Postan M, Martin D, et al. Frequency of interferon- gamma -producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease. J Infect Dis 2004; 189: 909-918.
13. Bonney KM, Taylor JM, Daniels MD, Epting CL & Engman DM. Heat-killed Trypanosoma cruzi induces acute cardiac damage and polyantigenic autoimmunity. PLoS ONE 2011; 6: e14571.
14. Ribeiro dos Santos R, Rossi MA, Laus JL, Silva JS, Silvino W & Mengels J. Anti-CD4 abrogates rejection and reestablishes long-term tolerance to syngeneic newborn hearts grafted in mice chronically infected with Trypanosoma cruzi. J Exp Med 1992; 175: 29-39.
15. Soares MB, Silva-Mota KN, Lima RS, Bellintani MC, Pontes-de-Carvalho L & Ribeiro-dos-Santos R. Modulation of chagasic cardiomyopathy by interleukin-4: dissociation between inflammation and tissue parasitism. Am J Pathol 2001; 159: 703-709.
16. Gomes JA, Bahia-Oliveira LM, Rocha MO, Martins-Filho OA, Gazzinelli G & Correa-Oliveira R. Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response. Infect Immun 2003; 71: 1185-1193.
17. Tibbetts RS, McCormick TS, Rowland EC, Miller SD & Engman DM. Cardiac antigen-specific autoantibody production is associated with cardiomyopathy in Trypanosoma cruzi-infected mice. J Immunol 1994; 152: 1493-1499.
18. Gruber A & Zingales B. Trypanosoma cruzi: characterization of two recombinant antigens with potential application in the diagnosis of Chagas' disease. Exp Parasitol 1993; 76: 1-12.
19. Borda ES & Sterin-Borda L. Antiadrenergic and muscarinic receptor antibodies in Chagas' cardiomyopathy. Int J Cardiol 1996; 54: 149-156.
20. Sterin-Borda L, Perez Leiros C, Wald M, Cremaschi G & Borda E. Antibodies to beta 1 and beta 2 adrenoreceptors in Chagas' disease. Clin Exp Immunol 1988; 74: 349-354.
21. Kaplan D, Ferrari I, Bergami PL, et al. Antibodies to ribosomal P proteins of Trypanosoma cruzi in Chagas disease possess functional autoreactivity with heart tissue and differ from anti-P autoantibodies in lupus. Proc Natl Acad Sci USA 1997; 94: 10301-10306.
22. Laguens RP, Meckert PC & Chambo JG. Antiheart antibody-dependent cytotoxicity in the sera from mice chronically infected with Trypanosoma cruzi. Infect Immun 1988; 56: 993-997.
23. Khoury EL, Ritacco V, Cossio PM, et al. Circulating antibodies to peripheral nerve in American trypanosomiasis (Chagas' disease). Clin Exp Immunol 1979; 36: 8-15.
24. Khoury EL, Diez C, Cossio PM & Arana RM. Heterophil nature of EVI antibody in Trypanosoma cruzi infection. Clin Immunol Immunopathol 1983; 27: 283-288.
25. Molina HA & Kierszenbaum F. Interaction of human eosinophils or neutrophils with Trypanosoma cruzi in vitro causes bystander cardiac cell damage. Immunology 1989; 66: 289-295.
26. Hoft DF & Eickhoff CS. Type 1 immunity provides optimal protection against both mucosal and systemic Trypanosoma cruzi challenges. Infect Immun 2002; 70: 6715-6725.
27. Guo S, Cobb D & Smeltz RB. T-bet inhibits the in vivo differentiation of parasite-specific CD4+ Th17 cells in a T cell-intrinsic manner. J Immunol 2009; 182: 6179-6186.
28. Dardalhon V, Korn T, Kuchroo VK & Anderson AC. Role of Th1 and Th17 cells in organ-specific autoimmunity. J Autoimmun 2008; 31: 252-256.
29. Cooke A. Th17 cells in inflammatory conditions. Rev Diabet Stud 2006; 3: 72-75.
30. Daniels MD, Hyland KV, Wang K & Engman DM. Recombinant cardiac myosin fragment induces experimental autoimmune myocarditis via activation of Th1 and Th17 immunity. Autoimmunity 2008; 41: 490-499.
31. Valaperti A, Marty RR, Kania G, et al. CD11b+ monocytes abrogate Th17 CD4+ T cell-mediated experimental autoimmune myocarditis. J Immunol 2008; 180: 2686-2695.
32. Liao L, Sindhwani R, Rojkind M, Factor S, Leinwand L & Diamond B. Antibody-mediated autoimmune myocarditis depends on genetically determined target organ sensitivity. J Exp Med 1995; 181: 1123-1131.
33. Hyland KV, Leon JS, Daniels MD, et al. Modulation of autoimmunity by treatment of an infectious disease. Infect Immun 2007; 75: 3641-3650.
34. Bermejo DA, Amezcua Vesely MC, Khan M, et al. Trypanosoma cruzi infection induces a massive extrafollicular and follicular splenic B-cell response which is a high source of non-parasite-specific antibodies. Immunology 2011; 132: 123-133.
35. Neumann DA, Lane JR, Wulff SM, et al. In vivo deposition of myosin-specific autoantibodies in the hearts of mice with experimental autoimmune myocarditis. J Immunol 1992; 148: 3806-3813.
36. Pellegrini A, Carrera-Silva EA, Arocena A, Cano RC, Aoki MP & Gea S. Trypanosoma cruzi antigen immunization induces a higher B cell survival in BALB/c mice, a susceptible strain, compared to C57BL/6 B lymphocytes, a resistant strain to cardiac autoimmunity. Med Microbiol Immunol 2011; 200: 209-218.
37. Watthanakulpanich D, Smith HV, Hobbs G, Whalley AJ & Billington D. Application of Toxocara canis excretory-secretory antigens and IgG subclass antibodies (IgG1-4) in serodiagnostic assays of human toxocariasis. Acta Trop 2008; 106: 90-95.
38. Cunha-Neto E, Bilate AM, Hyland KV, Fonseca SG, Kalil J & Engman DM. Induction of cardiac autoimmunity in Chagas heart disease: a case for molecular mimicry. Autoimmunity 2006; 39: 41-54.
39. Fujinami RS, von Herrath MG, Christen U & Whitton JL. Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin Microbiol Rev 2006; 19: 80-94.